" class="no-js "lang="en-US"> Ulf Hannelius - Medtech Alert
Wednesday, September 24, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Ulf Hannelius

Ulf Hannelius

About Ulf Hannelius

Life Science business professional and leader with 15+ years of experience in business development, strategy, innovation management and research.

Related Story

Fundraising

 Diamyd Medical and Partners are Awarded SEK 40 Million in VINNOVA Funding for the Prevention of Autoimmune Diseases | Pharmtech Focus

Diamyd Medical and Partners are Awarded SEK 40 Million in VINNOVA Funding for the Prevention of Autoimmune Diseases

September 24 2021

The Swedish governmental innovation agency VINNOVA provides SEK 40 million in financing for an innovation milieu in […]

Diseases

 Diamyd Medical Secures Precision Medicine Patent for Prevention and Treatment of Autoimmune Diabetes | Pharmtech Focus

Diamyd Medical Secures Precision Medicine Patent for Prevention and Treatment of Autoimmune Diabetes

August 9 2021

The European Patent Office has informed Diamyd Medical that the Company’s patent application regarding prevention […]